Results 91 to 100 of about 20,705 (157)

Development and validation of RP-HPLC method for Simultaneous Estimation of Formoterol Fumarate and Budesonide in their Combined Dosage Form [PDF]

open access: yes, 2018
AIM & OBJECTIVES: There is several basic criteria for new method development of drug molecules. For example a) The drug or drug combination may not be official in any pharmacopoeias b) A proper analytical procedure for the drug may not be available in ...
Kumar, A
core  

Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease

open access: yesFrontiers in Medicine
IntroductionMonoclonal antibodies (mAbs) against cytokines and chemokines or their receptors promise to be a potential therapeutic option to address chronic obstructive pulmonary disease (COPD).
Yu Xiong   +8 more
doaj   +1 more source

Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis

open access: yesBMC Pulmonary Medicine
Aim This study aims to systematically evaluate which single-inhaler triple therapy (inhaled corticosteroids [ICS], long-acting β2-agonists [LABA], and long-acting muscarinic antagonists [LAMA]) is safer and more effective for treating chronic obstructive
Yu Zhang, Pei Zhao, Yudong Zhang
doaj   +1 more source

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo

open access: yes, 2019
Combining inhaled corticosteroids (ICSs), long-acting β2 -adrenoceptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) is recommended to treat severe forms of asthma and chronic obstructive pulmonary disease (COPD). Clinical benefits have
Paola Rogliani   +11 more
core   +1 more source

Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD

open access: yes, 2016
Mafalda Ramos,1 John Haughney,2 Nathaniel Henry,3 Leandro Lindner,4 Mark Lamotte1 1Real World Evidence, IMS Health, Zaventem, Belgium; 2Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, 3Health ...
Ramos M   +4 more
core  

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap

open access: yesInternational Journal of COPD, 2020
Yoshihisa Ishiura,1,2 Masaki Fujimura,3 Noriyuki Ohkura,4 Johsuke Hara,4 Kazuo Kasahara,4 Nobuyasu Ishii,1 Yusuke Sawai,1 Toshiki Shimizu,1 Takeshi Tamaki,1 Shosaku Nomura1 1First Department of Internal Medicine, Kansai Medical University, Moriguchi ...
Ishiura Y   +9 more
doaj  

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

open access: yesInternational Journal of COPD, 2017
Dave Singh,1 Massimo Corradi,2 Monica Spinola,3 Alberto Papi,4 Omar S Usmani,5 Mario Scuri,3 Stefano Petruzzelli,3 Jørgen Vestbo1 1Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK; 2Department of ...
Singh D   +7 more
doaj  

From static difference to time-resolved spectroscopy of coupled electron and proton transfer in the quinol: fumarate reductase of Wolinella succinogenes [PDF]

open access: yes, 2011
The enzyme quinol:fumarate reductase (QFR) from the anaerobic epsilon-proteobacterium Wolinella succinogenes is a membrane protein complex that couples the catalysis of the oxidation of menaquinol to menaquinone to that of the reduction of fumarate to ...
Paul, Rajsekhar, Paul, R.
core  

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease

open access: yesInternational Journal of COPD, 2016
Maria Gabriella Matera,1 Alessandro Sanduzzi,2 Mario Cazzola3 1Department of Experimental Medicine, Second University of Naples, 2Department of Respiratory Diseases, Monaldi Hospital, University Federico II, Naples, 3Department of Systems Medicine ...
Matera MG, Sanduzzi A, Cazzola M
doaj  

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

open access: yesInternational Journal of COPD, 2013
Teddy Kosoglou,1 James Hubbell,2 Fengjuan Xuan,3 David L Cutler,1 Alan G Meehan,4 Bhavna Kantesaria,5 Bret A Wittmer6,† 1Clinical Pharmacology, 2Exploratory Drug Metabolism, 3Early Development Statistics, 4Medical Communications, 5Drug ...
Kosoglou T   +6 more
doaj  

Home - About - Disclaimer - Privacy